{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:18:08Z","timestamp":1790972288441,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.ejca.2007.04.023","type":"journal-article","created":{"date-parts":[[2007,6,16]],"date-time":"2007-06-16T14:11:18Z","timestamp":1182003078000},"page":"1713-1717","source":"Crossref","is-referenced-by-count":101,"title":["Genetic epidemiology of BRCA mutations \u2013 family history detects less than 50% of the mutation carriers"],"prefix":"10.1016","volume":"43","author":[{"given":"P\u00e5l","family":"M\u00f8ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Irene","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaran","family":"Apold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovise","family":"Maehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bent","family":"Fiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"L\u00f8vslett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eivind","family":"Hovig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Vab\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.ejca.2007.04.023_bib1","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/S0959-8049(03)00548-3","article-title":"The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer","volume":"39","author":"Heimdal","year":"2003","journal-title":"Eur J Cancer"},{"issue":"21","key":"10.1016\/j.ejca.2007.04.023_bib2","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 orBRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"issue":"30","key":"10.1016\/j.ejca.2007.04.023_bib3","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 andBRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol"},{"issue":"31","key":"10.1016\/j.ejca.2007.04.023_bib4","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of Ssort-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 andBRCA2 mutation carriers: The PROSE study group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2007.04.023_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.10641","article-title":"Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy","volume":"101","author":"M\u00f8ller","year":"2002","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2007.04.023_bib6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 andBRCA2 mutation carriers: the PROSE Study Group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1-3","key":"10.1016\/j.ejca.2007.04.023_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1155\/1999\/920109","article-title":"Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer","volume":"15","author":"Moller","year":"1999","journal-title":"Dis Markers"},{"issue":"5","key":"10.1016\/j.ejca.2007.04.023_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1023\/A:1025864703405","article-title":"Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway","volume":"12","author":"Bodd","year":"2003","journal-title":"J Genet Couns"},{"issue":"1","key":"10.1016\/j.ejca.2007.04.023_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10549-006-9182-3","article-title":"BRCA1-positive breast cancers in young women from Poland","volume":"99","author":"Lubinski","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ejca.2007.04.023_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10549-006-9261-5","article-title":"Direct-to-patient BRCA1 testing: the Twoj Styl experience","volume":"100","author":"Gronwald","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2007.04.023_bib11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0959-8049(01)00075-2","article-title":"TheBRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series","volume":"37","author":"M\u00f8ller","year":"2001","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2007.04.023_bib12","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1136\/jmg.2004.019687","article-title":"Ratio of female to male offspring of women tested for BRCA1 andBRCA2 mutations","volume":"41","author":"Kotar","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejca.2007.04.023_bib13","series-title":"Cancer in Norway. Cancer Registry of Norway","article-title":"Breast females","author":"Cancer Registry of Norway","year":"2004"},{"key":"10.1016\/j.ejca.2007.04.023_bib14","series-title":"\u00c5 vite eller ikke \u00e5 vite. Gentester ved arvelig kreft. Norwegian Government","author":"NOU","year":"1999"},{"issue":"18","key":"10.1016\/j.ejca.2007.04.023_bib15","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/S0959-8049(01)00299-4","article-title":"Genetic epidemiology of BRCA1 mutations in Norway","volume":"37","author":"Moller","year":"2001","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804907003504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804907003504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T15:56:06Z","timestamp":1546790166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804907003504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0959804907003504"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2007.04.023","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}